Overview
A. Vivo Capital LLC (“Vivo” or the “Firm”), formerly known as Vivo Ventures, LLC and BioAsia, LLC, is a
California limited liability company. Vivo has been in business since 1996 and has been a registered
investment adviser since 2014. Vivo serves as an investment adviser to pooled investment vehicles
(each, a “Fund” or a “Client” and collectively the “Funds” or “Clients”)1. Vivo’s Funds are reported on
Form ADV 1A. An affiliate of Vivo serves as the general partner (or similar managing body) of each
Fund. Vivo currently has over 40 investment professionals based both in the U.S. and in Greater China.
Vivo’s principal owner is Dr. Frank Kung.
B. Vivo is a global healthcare investment firm that focuses on finding and building value in healthcare
companies. Vivo invests in both public and private healthcare companies.
Vivo is affiliated with entities that serve as the general partners (or similar capacity with regards to
entities formed in other jurisdictions) to each of the Funds (each, a “General Partner” and, collectively,
the “General Partners”) and each of the Funds is controlled by its respective General Partner. The
following is a list of each of the General Partners of the Funds:
General Partners:
• Vivo Ventures VII, LLC
• Vivo Ventures Cayman VII (GP), L.P.
• Vivo Capital VIII, LLC
• Vivo Panda, LLC
• Vivo Opportunity, LLC
• Vivo Asia Opportunity, LLC
• Vivo Capital IX, LLC
• Vivo Capital IX (Cayman), LLC
• Vivo Innovation II, LLC
• Vivo Capital X, LLC
C. The investment focus and risks of the Funds are more particularly described in each Fund’s offering
and governing documents. These guidelines may provide for limits on the size, concentration,
geography, type of security and/or terms of the Fund’s investments. The Firm does not tailor its
advisory services to individual investors in its Funds.
D. The Firm does not participate in wrap fee programs.
1 “Fund” or “Client” means a private investment fund to which Vivo provides investment advice and/or invests on a
discretionary basis. The individuals and other persons that invest in the Vivo private investment funds are
generally referred to herein as “investors.” Unless otherwise expressly stated herein, the terms “Fund” and
“Client” do not include “investors.”
E. As of December 31, 2023, Vivo managed $5,809,839,447 in client assets on a discretionary basis. Vivo
does not manage any client assets on a non-discretionary basis.